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Abstract
In this work, we study the critical behavior of an epidemic propagation model that considers
individuals that can develop drug resistance. In our lattice model, each site can be found in one
of four states: empty, healthy, normally infected (not drug resistant) and strain infected (drug
resistant) states. The most relevant parameters in our model are related to the mortality, cure
and mutation rates. This model presents two distinct stationary active phases: a phase with co-
existing normal and drug resistant infected individuals and an intermediate active phase with only
drug resistant individuals. We employ a finite-size scaling analysis to compute the critical points
the critical exponents ratio β/ν governing the phase-transitions between these active states and
the absorbing inactive state. Our results are consistent with the hypothesis that these transitions
belong to the directed percolation universality class.
PACS numbers: 64.60.Ht, 05.70.Ln, 87.23.Cc, 87.19.Xx
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I. INTRODUCTION
The spread of epidemic processes in a population has been profusely studied by biolog-
ically oriented mathematicians mainly by the use of a set of partial differential equations
governing the time evolution of global variables such as the density of infected, refractory
and healthy individuals [1]. At high dimensions where local density fluctuations are neg-
ligible, this mean-field like approach gives the correct overall behavior of these systems,
according to renormalization group arguments. At low dimensions, density fluctuations be-
come relevant and microscopic approaches have to be considered. In general, most models of
epidemic propagation processes present a second order phase transition between a vacuum
and a stationary active state [2, 3, 4, 5, 6]. The vacuum corresponds to an absorbing state
towards which the system can evolve but from which it cannot leave. Systems with such
absorbing states cannot satisfy detailed balance due to the irreversible character of their
dynamics.
Nonequilibrium phase transitions from active fluctuating into inactive absorbing states
have been studied extensively for the last twenty years [3, 7, 8, 9, 10, 31]. These phase
transitions into absorbing states are characterized by a nonequilibrium critical behavior
similar to that of an equilibrium phase transition in many respects. One usually uses the
concept of scale invariance to understand nonequilibrium phase transitions with critical
exponents characterizing its universal behavior. These exponents allow us to categorize
nonequilibrium phase transitions into different universality classes. In reaction models for
the spread of epidemics, the density of infected individuals ρI acts as the order parameter,
vanishing in the absorbing state and having a finite average value in the active state. The
transition between the active and stationary state is achieved by tuning a typical reaction
rate λ that acts as the relevant control parameter. In the vicinity of the critical point, the
density of infected individuals vanishes as ρ ∝ (λ− λc)
β. Nonequilibrium phase transitions
are often characterized by spatial and temporal correlation lengths. Close to the transition
point, the spatial and temporal correlation lengths diverge as ξs ∝ (λ− λc)
−ν and ξt ∝ (λ−
λc)
−ν′. These two correlation length scales are related by ξs = ξ
z
t , where z = ν/ν
′ is called the
dynamic exponent. These three critical exponents ( β, ν, z) form the basic set of exponents
characterizing the universality class of a given reaction-diffusion process. It is generally
believed that nonequilibrium phase transitions into absorbing states can be categorized into
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a finite number of universality classes. Usually, systems presenting a continuous transition
to a single absorbing state belong to the directed percolation universality class [3, 11, 12].
However, some exceptions to this general rule have been recently reported to occur basically
in systems with a infinite number of absorbing states [13, 14, 15, 16, 17, 18] or with particle
diffusion [19, 20, 21].
In recent years, there has been a growing interest in studying diseases caused by organisms
that can mutate into drug resistant forms. One of the major reasons for the emergence of
such resistant organisms is the inappropriate use of the drugs used to combat them. Such is
the case, for example, when antibiotics are incorrectly administered to treat the tuberculosis
bacillus [22, 23], or the excessive use of anti-malaria drugs in Amazonia, Brazil [24, 25, 26,
27, 28]. Although these drugs are the only known effective treatments for such diseases,
their abuse can very quickly lead to the emergence of drug resistant mutant strains. For
example, while the exact mechanisms are not fully understood, strains have evolved that
are resistant to every drug used in Amazonia during the 1950’s and 60’s. To retard the
emergence of such resistant strains, measures are now being taken in the medical profession to
administer drugs only when needed, and giving preference to drug “cocktails” with multiple
components [26, 27, 28]. Recently, an epidemic spreading model with immunization and
mutations has been introduced[29]. The model also exhibits a phase transition belonging to
the directed percolation universality class and shows explicitly that the protection gained
by immunization is substantially decreased by the occurrence of mutations.
In this work, we will study a 1-dimensional stochastic epidemic propagation model consid-
ering the potential emergence of a population of drug resistant organisms. We will be mainly
interested in determining the stable phases and the scaling exponents governing the possible
phase transitions. The model presents two coupled order parameters, namely, the density
of drug sensitive and drug insensitive individuals. The coupling of an order parameter to
a fluctuating density has been shown to modify the universality class of the absorbing sate
phase transition in some models of population dynamics[30, 31]. By employing extensive
numerical simulations in finite populations and finite size scaling analysis, we will show that
an active phase emerges in which there is no drug sensitive individuals but a finite density
of drug resistant ones. The relative strength of the parameters controlling the processes
of healing, death and development of drug resistance, actually determines the stationary
population state. Further, we will show that all identified transitions in this model seem to
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belong to the directed percolation universality class.
II. BASIC MODEL FOR THE EMERGENCE OF DRUG RESISTANCE
Here, we will follow closely the ideas of [32]. Individuals distributed at random on a
given environment can be in three possible states, namely healthy, infected by normal strain
and infected by resistant strain. Birth of individuals will be introduced by considering that
a vacant site becomes occupied by a healthy individual at a rate β1. Infection occurs by
contact at a rate βini where ni is the number of infected neighbors and the index i stands
for normal (i = 2) and drug resistant (i = 3) states. Individuals infected with the normal
strain can heal at a rate pc. In what follows, we will consider that the healing rate is due
to drug administration, i.e., the spontaneous healing rate is negligible. Infected individuals
can also develop drug resistance at a rate pr. This process can be originated by both natural
mutations and bad drug administration. Individuals that develop drug resistance will not
be allowed to heal and die at a mortality rate pm. The average surviving-time of drug
resistant individuals is much smaller than the average life-time of individuals infected with
the normal strain, which will be taken as infinite in our simulations. The above dynamical
rules describing the processes of birth, death, healing, development of drug resistance and
infection by contact with normal or resistant strains are summarized in table 1. Notice that
the state with only healthy individuals is an absorbing one, since it is no longer possible for
anybody to become infected. Such is the case, for example, with small pox, which has been
eradicated.
A mean field approximation can be described using the following rate equations for the
average densities:
∂ρ1
∂t
= β1ρ0 − β2ρ1ρ2 − β3ρ1ρ3 + pcρ2
∂ρ2
∂t
= β2ρ1ρ2 − prρ2 − pcρ2
∂ρ3
∂t
= β3ρ1ρ3 + prρ2 − pmρ3
1 =
3∑
0
ρi
where a homogeneous, i.e., spatially uniform density of all populations was assumed. It is
straightforward to show that there are three possible stationary states: (i) the absorbing
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state with only healthy individuals; (ii) an active state where healthy individuals coexist
with individuals infected by normal and resistant organisms; and (iii) a second active state
where healthy and infected individuals coexist but all infected individuals have the resis-
tant organism. An important point to note is that normal organisms always coexists with
resistant organisms, i.e., a stationary active state without a drug resistant population is not
possible.
The basic contact process (CP), introduced by Harris [33] as a “toy model” for spreading
of disease, corresponds to the limiting case where only states 1 and 2 are allowed [13, 14, 34,
35]. The infection reaction rate is λn where n is the number of infected neighbors, and the
cure rate is 1, i.e. all sick individuals will recover in the next time step. Below the critical
threshold λ < λc, the absorbing state is reached, but for λ > λc a stationary active state
is possible. The model can also be applied to study the spread of a disease in the absence
of mutations. In this case, we have only states 0, 1 and 2. This model is known in the
literature as the forest fire model [36, 37, 38]. The above two limits have been extensively
investigated in the literature and accurate estimates of their critical exponents have shown
that they belong to the directed percolation universality class. Here, we are going to perform
extensive numerical simulations to obtain the full phase-diagram of the model allowing all
possible states.
III. NUMERICAL SIMULATIONS: PHASE DIAGRAMS AND CRITICAL EX-
PONENTS
We employed the above described model in finite one-dimensional chains with periodic
boundary conditions. Sites are considered to be vacant or occupied by an individual that
interacts with its nearest neighbors. The initial state corresponds to a random distribution
of healthy (η1) and infected (η2) individuals. For a given set of model parameters, we let
the system evolve towards a statistically stationary state. In what follows we are going to
restrict our study to the particular case of β1 = β2 = β3 = 1, letting as free parameters the
rates of mutation (pr), cure (pc) and mortality (pm). In our simulations, the statistically
stationary state was considered as reached after N = 104 lattice sweeps. Configurational
averages were performed by considering the subsequent 2 × 104 configurations. Finite size
simulations of dynamical systems exhibiting an absorbing state are usually compromised
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by the fact that this is the only stationary state. To avoid this feature, we reactivate
the dynamics whenever the absorbing state is reached by introducing a small density of
the critical order parameter. The dynamics follows the rules of contamination, healing,
mutation, death and birth processes summarized in table 1. In addition to these rules, the
contamination of a healthy individual that is surrounded by both kinds of infected sites is
chosen to be preferentially updated to state η3 (resistant strain).
In figure 1, we show the equilibrium density of normally infected individuals (ρ2) and
drug resistant ones (ρ3) as obtained from simulations on chains with L = 800 sites for three
characteristic values of the mutation rate pr. We observe that the absorbing state is the
equilibrium state for large values of cure and mortality rates. Two distinct active stationary
regimes are also clearly identified. The first one corresponds to a state with zero density
of normally infected but with a finite density of drug resistant ones. This phase is stable
at low death rates and its emergence is independent of the mutation rate pr 6= 0. The
large surviving time of drug resistant individuals in this regime favors the contamination
process. The second active state has co-existing densities of normal and drug resistant
infected individuals. It emerges in the regime of low cure rates but disappears for large
mutation rates. A direct transition between these active states takes place at low death and
cure rates.
In order to closely investigate the transition between the active state with co-existing
densities and the absorbing state, we computed the order parameter densities for pc = 0
(no healing), which is the most favorable case for co-existence. In figure 2, we show the
relevant densities as function of pr and pm. Notice that there is a critical mutation rate
above which the phase with co-existing densities disappears. The maximum value for the
critical mutation rate is attained for pm = 1. To have an accurate estimate of the critical
parameters, we employed a finite size scaling analysis of our numerical data. Figure 3 shows
the density ρ2 as a function of the mutation rate for the special case of pc = 0 and pm = 1
and several chain sizes. The data suggest a continuous transition near pr = 0.175. A
numerical renormalization group analysis of the above data can provide a better estimate
of the critical value. This procedure explores the finite size scaling relation that the order
parameter density is expected to obey at the vicinity of the critical point, namely
ρ2(L, pr) = L
−β/νf [(pr − p
∗
r)L
1/ν ] . (1)
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Therefore, one can construct a family of auxiliary functions
g(pr, L, L
′) =
ln ρ2(L, pr)/ρ2(L
′, pr)
lnL/L′
. (2)
According to the finite size scaling hypothesis, these auxiliary functions shall all intercept at
the critical point and g(p∗r) = −β/ν. In figure 4, we report the above scaling analysis to the
data shown in figure 3. All curves obtained from distinct pairs of lattice sizes intercept nearly
at the same point. Without considering any correction to scaling, we obtain an accurate
estimate of p∗r = 0.176(1) and the critical exponents ratio β/ν = 0.25(1). The above
finite-size scaling analysis was employed to obtain the full phase diagram in the absence of
treatment (pc = 0) as shown in figure 5. The absorbing healthy state (H) is always the
equilibrium one at large mutation and mortality rates. The phase diagram exhibits three
distinct phase transitions. For mortality rates above p∗m = 0.224(1), the active state is
the one with co-existing densities of normal (N) and resistant (R) individuals which is the
stationary state at small pr. For mortality rates below p
∗
m the stationary state is always
active, as the long surviving-time of infected individuals makes the contamination process
the predominant one. However, there is a transition between the active co-existing state
at small pr to the active state with a finite density of drug resistant individuals and a
zero density of normal individuals at large pr. Notice that at intermediate mutation rates pr
the phase-diagram presents re-entrant transitions with the sequence of active-inactive-active
equilibrium states appearing with increasing mortality rates pm. In all cases, the measured
values of β/ν were consistent with these transitions belonging to the directed percolation
universality class. In figure 6 we illustrate the main phase-diagram for a fixed mutation rate.
In this case, the absorbing state is the equilibrium state at large cure and mortality rates. At
low mortality rates [below the critical value p∗m = 0.224(1)], there is always a finite density
of drug resistant individuals. With increasing cure rate pc a transition between the active
co-existing state and the absorbing state can takes place. The line delimiting this transition
saturates at a maximum critical cure rate p∗c(pr = 0.05) = 0.219(1) which decreases with
increasing mutation rates. Further, this co-existing phase is only stable for mortality rates
larger than p∗m(pr = 0.05) = 0.168(1) and moves to larger values as pr increases. At small
mutation rates the above two lines intercept (as shown in the figure) and a direct transition
between the two possible active states can take place. On the other hand, at the limiting
value of p∗r = 0.176(1) the NR to H transition line disappears and the co-existing phase is
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no longer stable. Re-entrant sequence of active-inactive-active equilibrium states can also
be achieved at intermediate cure rates.
IV. SUMMARY AND CONCLUSIONS
We have studied a stochastic epidemic model in a 1-dimensional lattice which considers
the possibility of individuals to develop drug resistance. Individuals with the normal disease
may heal due to drug administration but those with the resistant strain do not heal and
die at a finite mortality rate. We numerically simulated this model of population dynamics
in finite chains with periodic boundary conditions and investigated the properties of the
stationary states. The model presents one absorbing inactive state with only healthy indi-
viduals. There is also a main active stationary state with fluctuating densities of normal
and drug resistant infected individuals. Further, an intermediate active stationary state
with no normally infected individuals and a fluctuating density of drug resistant ones is also
realizable. This state can be the stationary one only when the mortality rate is below a
critical threshold p∗m = 0.224, since under this condition the long surviving-time of drug
resistant individuals potentialize this epidemic process. For mortality rates above the crit-
ical threshold a transition between the main active to the absorbing state takes place with
increasing cure rates. We reported typical phase-diagrams showing the stationary states as
a function of the main transition rates. The phase-diagram exhibits re-entrant regions and
a direct transition between the main and intermediate active states at low mutation rates.
We further employed a finite-size scaling analysis to compute the exponent ratio β/ν which
is consistent with these transitions belonging to the directed percolation universality class.
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EVENT EFFECT TRANSITION RATE
Birth (η0, η1)→ (η0 − 1, η1 + 1) β1
Infected by contact (η1, η2)→ (η1 − 1, η2 + 1) β2n2
Infected by contact (η1, η3)→ (η1 − 1, η3 + 1) β3n3
Mutation (η2, η3)→ (η2 − 1, η3 + 1) pr
Cure (η2, η1)→ (η2 − 1, η1 + 1) pc
Death (η3, η0)→ (η3 − 1, η0 + 1) pm
TABLE I: Summary of the relevant processes, their effects on the population and transition rates
for the present epidemic model with drug resistance.
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FIG. 1: The stationary densities of normally infected (ρ2) and drug resistant (ρ3) individuals as a
function of cure rate (pc) and mortality rate (pm) for typical mutation rates. The three possible
stationary states are clearly identified, namely, the absorbing state (ρ2 = ρ3 = 0), the main active
state (finite ρ2 and ρ3) and the intermediate active state (ρ2 = 0 and finite ρ3). The intermediate
active state is practically independent of the cure and mutation rates. The main active state is
only stable for small mutation rates and disappears for pr > p
∗
r = 0.176.
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FIG. 2: The stationary densities of normally infected (ρ2) and drug resistant (ρ3) individuals as
a function of mutation and mortality rates for the special case of pc = 0 (no healing). Here the
transition from the main active to the absorbing state is better illustrated. In this phase a small
density of drug resistant individuals co-exists with a large density of normally infected ones.
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FIG. 3: The stationary density of normally infected individuals (ρ2) versus the mutation rate pr
for the limiting case of pc = 0 and pm = 1. Results from simulations on chains with different sizes
are shown. The continuous phase transition from the active to the absorbing state is smoothed by
finite size effects.
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FIG. 4: Numerical renormalization group of the same data from figure 3 in the vicinity of the
transition point. Renormalization using several pairs of chain sizes are shown. All auxiliary
functions intercept at a common point which determines the critical value p∗r = 0.176(1) and the
critical exponents ratio β/ν = 0.25(1). This exponent is consistent with this transition belonging
to the directed percolation universality class.
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FIG. 5: Phase-diagram for the special case of pc = 0. The absorbing state (H) is only stable for
mortality rates above p∗m = 0.224(1). In this region, a transition from the main active (NR) to the
absorbing state (H) occurs for increasing mutation rates. The absorbing state is reached trough the
death process. Below p∗m there is a transition between the main active (NR) to the intermediate
active state (R).
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FIG. 6: Phase-diagram for a typical mutation rate pr = 0.05. For low mortality rates the stationary
state is again always active and mostly with drug resistant individuals. The main active state may
be stable at small cure rates. Above the critical mortality rate the transition from the active (NR)
to the absorbing (H) state takes place with increasing cure rates. In this region the absorbing state
is reached through both death and cure process.
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